The Laboratory Risk Indicator for Necrotizing Fasciitis score for discernment of necrotizing fasciitis originated from Vibrio vulnificus infections

Journal of Trauma and Acute Care Surgery

Volumn 73, Issue 6, 2012, Pages 1576-1582

  Chao, Wai Nang ^a,e   Tsai, Shih Jei ^a   Tsai, Chin Feng ^a,b   Su, Chun Hung ^a,b   Chan, Khee Siang ^a,e   Lee, Yuan Ti ^a,b   Ueng, Kwo Chang ^a,b   Lin, Ding Bang ^a,b   Chen, Chun Chieh ^a,b   Chen, Shiuan Chih ^a,b,c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

case management; early diagnosis; necrotizing fasciitis; skin and soft tissue infections; Vibro species

Indexed keywords

ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CEPHALOSPORIN; CREATININE; GLUCOSE; HEMOGLOBIN; MINOCYCLINE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLISTER; COMORBIDITY; CREATININE BLOOD LEVEL; DEBRIDEMENT; FASCIOTOMY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFECTION RISK; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NECROTIZING FASCIITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SKIN INFECTION; SODIUM BLOOD LEVEL; SOFT TISSUE INFECTION; TREATMENT OUTCOME; VESICULAR RASH; VIBRIO VULNIFICUS INFECTION;

DECISION SUPPORT TECHNIQUES; FASCIITIS, NECROTIZING; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SKIN; SOFT TISSUE INFECTIONS; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

EID: 84871255157     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e318270d761     Document Type: Article

References (40)

1. Salcido RS. Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care. 2007;20:288-293.
2. Kaul R, McGeer A, Low DE, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18-24.
3. Ellis Simonsen SM, van Orman ER, Hatch BE, et al. Cellulitis incidence in a defined population. Epidemiol Infect. 2006;134:293-299.
4. Tillou A, St Hill CR, Brown C, Velmahos G. Necrotizing soft tissue infections: improved outcomes with modern care. Am Surg. 2004;70: 841-844.
5. Hsiao CT,Weng HH, Yuan YD, Chen CT, Chen IC. Predictors of mortality in patients with necrotizing fasciitis. Am J Emerg Med. 2008;26:170-175.
6. Frazee BW, Fee C, Lynn J, et al. Community-acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emerg Med. 2008;34:139-146.
7. Dworkin MS, Westercamp MD, Park L, McIntyre A. The epidemiology of necrotizing fasciitis including factors associated with death and amputation. Epidemiol Infect. 2009;137:1609-1614.
8. Hong YC, Chou MH, Liu EH, et al. The effect of prolonged ED stay on outcome in patients with necrotizing fasciitis. Am J Emerg Med. 2009;27: 385-390.
9. Boyer A, Vargas F, Coste F, et al. Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med. 2009;35:847-853.
10. Nisbet M, Ansell G, Lang S, Taylor S, Dzendrowskyj P, Holland D. Necrotizing fasciitis: review of 82 cases in South Auckland. Intern Med J. 2011;41:543-548.
11. Vinh DC, Embil JM. Rapidly progressive soft tissue infections. Lancet Infect Dis. 2005;5:501-513.
12. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705-710.
13. Ustin JS, Malangoni MA. Necrotizing soft-tissue infections. Crit Care Med. 2011;39:2156-2162.
14. Rahmouni A, Chosidow O, Mathieu D, et al. MR imaging in acute infectious cellulites. Radiology. 1994; 192:493-496.
15. Majeski J, Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J. 1997;90:1065-1068.
16. Wysoki MG, Santora TA, Shah RM, et al. Necrotizing fasciitis: CT characteristics. Radiology. 1997;203:859-863.
17. Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis from cellulites using MR imaging. AJR Am J Roentgenol. 1998;170: 615-620.
18. Brothers TE, Tagge DU, Stutley JE, et al. Magnetic resonance imaging differentiates between necrotizing and non-necrotizing fasciitis of the lower extremity. J Am Coll Surg. 1998;187:416-421.
19. Wong CH, Khin LW, Heng KS. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32:1535-1541.
20. Chen SC, Chan KS, Chao WN, et al. Clinical outcomes and prognostic factors for patients with Vibrio vulnificus infections requiring intensive care: a 10-yr retrospective study. Crit Care Med. 2010;38:1984-1990.
21. Tsai YH, Hsu RW, Huang TJ, et al. Necrotizing soft-tissue infections and sepsis caused by Vibrio vulnificus compared with those caused by Aeromonas species. J Bone Joint Surg Am. 2007;89:631-636.
22. Tsai YH, Hsu RWW, Huang KC, et al. Comparison of necrotizing fasciitis and sepsis caused by Vibrio vulnificus and Staphylococcus aureus. J Bone Joint Surg Am. 2011;93:274-284.
23. Abbott SL, Janda JM, Johnson JA, et al. Vibrio and related organisms. In: Murray PR, Baron EJ, Jorgensen JH, et al, eds. Manual of Clinical Microbiology. Vol. I. 9th ed.Washington, DC: ASM Press; 2007: 723-733.
24. Stamenkovic I, Lew PD. Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. N Engl J Med. 1984;310: 1689-1693.
25. Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology and determinants of mortality. J Bone Joint Surg Am. 2003;85:1454-1460.
26. Blake PA, Merson MH, Weaver RE, et al. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med. 1979; 300:1-5.
27. Klontz KC, Lieb S, Schreiber M, et al. Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med. 1988;109:318-323.
28. Chuang YC, Yuan CY, Liu CY, et al. Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis. 1992;15:271-276.
29. Howard RJ, Bennett NT. Infections caused by halophilic marine Vibrio bacteria. Ann Surg. 1993;217:525-530.
30. Hlady WG, Klontz KC. The epidemiology of Vibrio infections in Florida, 1981-1993. J Infect Dis. 1996;173:1176-1183.
31. Hsueh PR, Lin CY, Tang HJ, et al. Vibrio vulnificus in Taiwan. Emerg Infect Dis. 2004;10:1363-1368.
32. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530-538.
33. Guidelines for intensive care unit admission, discharge, and triage Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med. 1999;27:633-638.
34. Youden WJ. An index for rating diagnostic tests. Cancer. 1950;3:32-35.
35. Park SD, Shon HS, Joh NJ. Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J Am Acad Dermatol. 1991;24:397-403.
36. Halow KD, Harner RC, Fontenelle LJ. Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention. J Am Coll Surg. 1996;183:329-334.
37. Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208:279-288.
38. Chiang SR, Chuang YC. Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect. 2003;36:81-88.
39. Liu JW, Lee IK, Tang HJ, et al. Prognostic factors and antibiotics in Vibrio vulnificus septicemia. Arch Intern Med. 2006;166:2117-2123.
40. Chen SC, Lee YT, Tsai SJ, et al. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period. J Antimicrob Chemother. 2012;67:488-493.